277 (Januvia 100 mg)
Generic Name: sitagliptin
Pill imprint 277 has been identified as Januvia 100 mg.
Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- sitagliptin
- Imprint:
- 277
- Strength:
- 100 mg
- Color:
- Brown
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Merck & Company Inc.
- National Drug Code (NDC):
- 00006-0277
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
ferric oxide red
sodium stearyl fumarate
magnesium silicate
titanium dioxide
ferric oxide yellow
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5925 | A-S Medication Solutions, LLC (repackager) |
| 54868-5840 | Physicians Total Care Inc (repackager) |
| 35356-0103 | Lake Erie Medical and Surgical Supply (repackager) |
| 68258-5990 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
More about Januvia (sitagliptin)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
